5 Most Valuable Drug Companies in 2024

2. Novo Nordisk A/S (NYSE:NVO)

Market Capitalization: $527.53 Billion

Novo Nordisk A/S (NYSE:NVO) is a Danish multinational pharmaceutical company that ranks second on our list of most valuable drug companies in 2024. It develops, produces, and markets pharmaceutical products with a focus on diabetes care, insulin delivery systems, and other diabetes products. As of February 8, 2024, Novo Nordisk A/S (NYSE:NVO) has a market capitalization of $527.53 billion.

Follow Novo Nordisk A S (NYSE:NVO)